Dr. David Kideckel is a Director and Equity Research Analyst at Beacon Securities Limited. He is an industry veteran, having spent nearly 10 years in "Big Pharma," medical devices and biotechnology companies, in increasing roles of responsibility. Dr. Kideckel completed his Doctorate in neurosciences at University of Toronto's Institute of Medical Science, spanning cross-departmental synergies in brain imaging, behavioral and cognitive neuroscience as well as movement disorders. Dr. Kideckel has been cited in feature journal as "Science's Business Man."